中文名 | FH535 |
英文名 | FH535 |
别名 | 化合物FH535 2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺 |
英文别名 | FH535 FH 535 CS-1433 FH 535(FH-535) 2,5-Dichloro-N-(2-Methyl-4-nitrophenyl)benzenesulfonaMide N-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonaMide 2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide FH535 |
CAS | 108409-83-2 |
化学式 | C13H10Cl2N2O4S |
分子量 | 361.2 |
InChIKey | AXNUEXXEQGQWPA-UHFFFAOYSA-N |
密度 | 1.566±0.06 g/cm3(Predicted) |
熔点 | 141-142℃ |
沸点 | 526.3±60.0 °C(Predicted) |
溶解度 | DMSO: 可溶物20mg/mL |
酸度系数 | 5.83±0.10(Predicted) |
存储条件 | 2-8°C |
稳定性 | 从提供的购买之日起稳定2年。在DMSO中的溶液可以在-20 ° 储存长达2个月。 |
外观 | 黄色固体 |
颜色 | Tan |
体外研究 | FH535 is an inhibitor of Wnt/β-catenin and PPAR. FH535 inhibits PPARγ and PPARδ transactivation in HCT116 cells. FH535 (15 μM) activities depend on functional PPARδ but does not require a cysteine residue in the PPAR ligand-binding domain. FH535 inhibits recruitment of the coactivators GRIP1 and β-catenin to PPARδ and PPARγ. FH535 shows toxic effects on 12 carcinoma cell lines expressing wnt/β-catenin pathway. FH535 (20 μM) suppresses the β-catenin pathway in pancreatic cancer cells, and inhibits pancreatic cancer cell migration. Furthermore, FH535 (20, 40 μM) inhibits pancreatic cancer cell invasion and cell growth. FH535 represses angiogenesis-related genes in pancreatic cancer cells. |
体内研究 | FH535 (25 mg/kg, i.p.) exhibits an anti-tumor effect on pancreatic cancer xenografts in mice. FH535 also represses angiogenesis in pancreatic cancer xenografts. |
危险品标志 | Xi - 刺激性物品 |
风险术语 | 41 - 对眼睛有严重伤害。 |
安全术语 | 36 - 穿戴适当的防护服。 |
WGK Germany | 3 |
海关编号 | 29350090 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.769 ml | 13.843 ml | 27.685 ml |
5 mM | 0.554 ml | 2.769 ml | 5.537 ml |
10 mM | 0.277 ml | 1.384 ml | 2.769 ml |
5 mM | 0.055 ml | 0.277 ml | 0.554 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!